First Wave BioPharma (NASDAQ:FWBI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by equities research analysts at HC Wainwright in a report issued on Monday, Benzinga reports. Separately, Roth Mkm cut their price target on First Wave BioPharma from $40.00 to $36.00 and set a “buy” rating on the stock in a report […]
First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Free Report) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 176,600 shares, an increase of 39.7% from the January 15th total of 126,400 shares. Approximately 28.7% of the company’s stock are sold short. Based on […]
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Free Report) traded down 3% during mid-day trading on Thursday . The stock traded as low as $4.95 and last traded at $5.14. 159,133 shares changed hands during trading, a decline of 75% from the average session volume of 644,631 shares. The stock had previously closed at $5.30. […]
First Wave BioPharma to Present at the DealFlow MicroCap Conference tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.